Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

39.57
-1.6126-3.92%
Post-market: 39.570.00000.00%16:14 EDT
Volume:30.05K
Turnover:1.20M
Market Cap:33.63M
PE:- -
High:41.15
Open:40.89
Low:39.46
Close:41.18
52wk High:44.10
52wk Low:13.42
Shares:850.00K
Float Shares:850.00K
Volume Ratio:1.91
T/O Rate:3.54%
Dividend:0.66
Dividend Rate:1.66%
ROE:--
ROA:--
PB:0.76
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Virtus LifeSci Biotech Clinical Trials ETF
Exchange:
ARCA
Establishment Date:
2014
Employees:
- -
Office Location:
One Financial Plaza,26th Floor,Hartford,Connecticut,United States
Website:
- -
Zip Code:
06103
Fax:
860-241-1024
Introduction:
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.